Clinical Trials Directory

Trials / Unknown

UnknownNCT01860690

BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Meir Medical Center · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The investigators want to compeer BHCG levels after Methotrexate ( MTX). treatment for Ectopic pregnancy in days 4 and 7 after MTX. to day 10 . The hypothesis is that "BHCG" level in day 10 is the best indicator for treatment success , superior to day 4 and 7 . According to the investigators impression BHCG level rises in days 4 and 7 due to destruction of the trophoblast tissue , and only day 10 is an indicator for treatment success

Conditions

Interventions

TypeNameDescription
DRUGMethotrexate50 mg / meter squer Intramuscular (IM) MTX.

Timeline

Start date
2011-11-01
Primary completion
2013-11-01
Completion
2014-02-01
First posted
2013-05-23
Last updated
2013-05-23

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01860690. Inclusion in this directory is not an endorsement.